Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lung

The standard-of-care for advanced small cell lung cancer (SCLC) is chemotherapy with cisplatin+etoposide (C+E). Most patients have chemosensitive disease at the outset, but disease frequently relapses and limits survival. Efforts to improve therapeutic outcomes in SCLC and other neuroendocrine cance...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Anticancer Drugs
Main Authors: Balasubramaniam, Sanjeeve, Redon, Christophe E., Peer, Cody J., Bryla, Christine, Lee, Min-Jung, Trepel, Jane B., Tomita, Yusuke, Rajan, Arun, Giaccone, Giuseppe, Bonner, William M., Figg, William D., Fojo, Tito, Piekarz, Richard L., Bates, Susan E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6631369/
https://ncbi.nlm.nih.gov/pubmed/29420340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0000000000000596
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados